IL264538A - - Google Patents

Info

Publication number
IL264538A
IL264538A IL26453819A IL26453819A IL264538A IL 264538 A IL264538 A IL 264538A IL 26453819 A IL26453819 A IL 26453819A IL 26453819 A IL26453819 A IL 26453819A IL 264538 A IL264538 A IL 264538A
Authority
IL
Israel
Application number
IL26453819A
Other languages
English (en)
Other versions
IL264538B2 (en
IL264538B (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IL264538A publication Critical patent/IL264538A/en
Publication of IL264538B publication Critical patent/IL264538B/en
Publication of IL264538B2 publication Critical patent/IL264538B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL264538A 2016-08-05 2019-01-29 A new use of n,n-bis-2-mercaptoethyl isophthalamide IL264538B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201613535 2016-08-05
PCT/GB2017/052306 WO2018025049A1 (en) 2016-08-05 2017-08-04 New use of n,n-bis-2-mercaptoethyl isophthalamide

Publications (3)

Publication Number Publication Date
IL264538A true IL264538A (cg-RX-API-DMAC10.html) 2019-03-31
IL264538B IL264538B (en) 2022-10-01
IL264538B2 IL264538B2 (en) 2023-02-01

Family

ID=60202272

Family Applications (1)

Application Number Title Priority Date Filing Date
IL264538A IL264538B2 (en) 2016-08-05 2019-01-29 A new use of n,n-bis-2-mercaptoethyl isophthalamide

Country Status (30)

Country Link
US (2) US20190240173A1 (cg-RX-API-DMAC10.html)
EP (2) EP4029497A1 (cg-RX-API-DMAC10.html)
JP (1) JP6926192B2 (cg-RX-API-DMAC10.html)
KR (1) KR102538388B1 (cg-RX-API-DMAC10.html)
CN (2) CN121926911A (cg-RX-API-DMAC10.html)
AU (1) AU2017305661B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019002130A2 (cg-RX-API-DMAC10.html)
CL (1) CL2019000229A1 (cg-RX-API-DMAC10.html)
CY (1) CY1125039T1 (cg-RX-API-DMAC10.html)
DK (1) DK3493849T3 (cg-RX-API-DMAC10.html)
EA (1) EA201990443A1 (cg-RX-API-DMAC10.html)
ES (1) ES2907838T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20220252T1 (cg-RX-API-DMAC10.html)
HU (1) HUE057782T2 (cg-RX-API-DMAC10.html)
IL (1) IL264538B2 (cg-RX-API-DMAC10.html)
LT (1) LT3493849T (cg-RX-API-DMAC10.html)
MA (1) MA45855B1 (cg-RX-API-DMAC10.html)
MD (1) MD3493849T2 (cg-RX-API-DMAC10.html)
MX (1) MX387853B (cg-RX-API-DMAC10.html)
MY (1) MY199733A (cg-RX-API-DMAC10.html)
PH (1) PH12019500237A1 (cg-RX-API-DMAC10.html)
PL (1) PL3493849T3 (cg-RX-API-DMAC10.html)
PT (1) PT3493849T (cg-RX-API-DMAC10.html)
RS (1) RS62924B1 (cg-RX-API-DMAC10.html)
SG (1) SG11201900565RA (cg-RX-API-DMAC10.html)
SI (1) SI3493849T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202200109T1 (cg-RX-API-DMAC10.html)
UA (1) UA125394C2 (cg-RX-API-DMAC10.html)
WO (1) WO2018025049A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201900594B (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use
WO2026037909A1 (en) * 2024-08-16 2026-02-19 Emeramed Limited N,n-bis-2-mercaptoethyl isophthalamide for use in the treatment of pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
US8950583B2 (en) * 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
US20120122787A1 (en) * 2009-07-10 2012-05-17 Rong Li Methods for treating polycystic kidney disease (pkd) or other cyst forming diseases
JP2013505963A (ja) 2009-09-28 2013-02-21 ユニヴァーシティ オブ ケンタッキー リサーチ ファウンデイション 汚染された環境から元素を除去するチオール含有化合物およびその使用方法
US8575218B2 (en) 2009-09-28 2013-11-05 The University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from tissues and formulations therefor
US20110237776A1 (en) 2010-03-25 2011-09-29 Haley Boyd E Aromatic compounds with sulfur containing ligands
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet

Also Published As

Publication number Publication date
KR102538388B1 (ko) 2023-05-30
EA201990443A1 (ru) 2019-07-31
JP2019524782A (ja) 2019-09-05
PT3493849T (pt) 2022-02-23
EP3493849B1 (en) 2021-12-01
SMT202200109T1 (it) 2022-05-12
BR112019002130A2 (pt) 2019-05-14
KR20190035724A (ko) 2019-04-03
RS62924B1 (sr) 2022-03-31
PL3493849T3 (pl) 2022-03-28
MY199733A (en) 2023-11-21
WO2018025049A1 (en) 2018-02-08
SI3493849T1 (sl) 2022-04-29
MX2019000978A (es) 2019-06-10
MA45855B1 (fr) 2022-02-28
JP6926192B2 (ja) 2021-08-25
IL264538B2 (en) 2023-02-01
PH12019500237A1 (en) 2019-10-28
CN109562179A (zh) 2019-04-02
CL2019000229A1 (es) 2019-04-26
MD3493849T2 (ro) 2022-04-30
EP4029497A1 (en) 2022-07-20
US20250325503A1 (en) 2025-10-23
IL264538B (en) 2022-10-01
MA45855A (fr) 2021-03-17
CA3032858A1 (en) 2018-02-08
LT3493849T (lt) 2022-03-10
DK3493849T3 (en) 2022-03-07
HUE057782T2 (hu) 2022-06-28
CY1125039T1 (el) 2023-03-24
AU2017305661A1 (en) 2019-02-14
US20190240173A1 (en) 2019-08-08
UA125394C2 (uk) 2022-03-02
CN121926911A (zh) 2026-04-28
MX387853B (es) 2025-03-19
NZ750271A (en) 2025-07-25
ES2907838T3 (es) 2022-04-26
HRP20220252T1 (hr) 2022-04-29
AU2017305661B2 (en) 2023-05-18
SG11201900565RA (en) 2019-02-27
ZA201900594B (en) 2019-08-28
EP3493849A1 (en) 2019-06-12

Similar Documents

Publication Publication Date Title
BR112019002665A2 (cg-RX-API-DMAC10.html)
BR112018004986A2 (cg-RX-API-DMAC10.html)
BR112019008105A2 (cg-RX-API-DMAC10.html)
BR112019001429A2 (cg-RX-API-DMAC10.html)
BR212018070320U2 (cg-RX-API-DMAC10.html)
BR112019011044B1 (pt) Compostos de pirazol substituído, seu uso, e composição farmacêutica
BR112019008501B1 (pt) Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador
BR112019003116B1 (pt) Configuração de símbolo de rajada comum de uplink
BR112019000061B1 (pt) Comutação e modulação de splicing de pré-mrna compreendendo porções de arcabouço bicíclico, com características melhoradas para o tratamento de distúrbios genéticos
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR112018072681B1 (pt) Anticorpos anti-il-1r3 humanizados, fragmento ou derivado do mesmo, seu uso e composição farmacêutica
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112019006736A2 (cg-RX-API-DMAC10.html)
CN303610852S (zh) 包装桶(醇自然罗平菜油二)
CN303655140S (zh) 带有资产管理信息系统界面的电脑(使用人版)
CN303537476S (zh) 飞碟吊椅
CN303548232S (zh) 水杯(3012)
CN303553797S (zh) 热风梳
CN303537540S (zh) 床(多功能太空舱式)
CN303536045S (zh) 嫁衣(15)
CN303537535S (zh) 车家床(四六分圆拉床半围)
CN303536114S (zh) 儿童洗头帽
CN303536111S (zh) 眼罩(条纹)
CN303536110S (zh) 眼罩(花纹)